UCB (UCB)

Index:

BEL 20

  260.20
   
  • Change Today:
     3.60
  • 52 Week High:  263.20
  • 52 Week Low:  129.35
  • Currency: Euro
  • Shares Issued: 190.00m
  • Volume: 194,050
  • Market Cap:  49,438m
  • Beta: 1.78

Latest ShareCast News

Belgium's UCB to buy US-based Ra Pharmaceuticals for $2.1bn

By Michele Maatouk

Date: Thursday 10 Oct 2019

(Sharecast News) - Belgian drug maker UCB has agreed to buy US-based clinical-stage biopharmaceuticals company Ra Pharmaceuticals for $2.1bn.

UCB ShareCast News

No recent information was found.

UCB Newspaper Links

GSK gets emerging markets boost with UCB deal 24-Jan-2009 Telegraph
UCB confident on drug go-ahead 21-Aug-2007 The Scotsman
Fellner shuffles Acambis board 08-Mar-2007 Telegraph
Deal speeds drugs sector consolidation 26-Sep-2006 The Herald

UCB Tips & Analysis

No recent information was found.

UCB News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

UCB Market Data

Currency Euro
Share Price   260.20
Change Today   3.60
% Change 1.40 %
52 Week High  263.20
52 Week Low  129.35
Volume 194,050
Shares Issued 190.00m
Market Cap  49,438m
Beta 1.78

Trades for 09-Oct-2025

Time Volume / Share Price
17:35 73 @  260.20
17:35 28 @  260.20
17:35 37 @  260.20
17:35 35 @  260.20
17:35 731 @  260.20

Top of Page